Mahshid Naser Langroodi

Mahshid Naser Langroodi

Auto-generated profile, based on publicly available information

Mahshid Naser Langroodi

Department of Internal Medicine, Guilan University of Medical Sciences, Rasht, Iran

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2024 in Journal of Research in Clinical Medicine
Verified
Journal Article
Open access
PDF file
MLMahshid Naser Langroodi
Mahshid Naser Langroodi
AAAkbar Aliasgharzadeh
Akbar Aliasgharzadeh
MNMostafa Najafipour
Mostafa Najafipour
NYNeda Lotfi Yagin
Neda Lotfi Yagin
FNFarzad Najafipour
Farzad Najafipour
Introduction: Acromegaly, characterized by overproduction of growth hormone (GH) and insulin-like growth factor 1 (IGF1), increases the risk of mortality and morbidities. Monitoring is a crucial aspect of managing and treating of acromegaly patients. In various studies, patients with active acromegaly have shown discordance between GH and IGF-1 results after surgery. In this study, the discrepancy between these two tests in monitoring acromegaly patients was evaluated. Methods: The levels of IGF-1 and GH after OGTT in 49 acromegalic patients who underwent surgery at least 3 months earlier and had been referred to clinic for follow-up were analyzed. Clinical and metabolic parameters, GH nadir, and IGF-1 values were compared between groups. Results: Fifty-one percent of patients had normal IGF-1 based on their age and sex, and 57.1% of patients had GHn<1 µg/L. Based on IGF-1 and GHn results, 23 patients had discordant results. The most common pattern of discordance was high IGF-1 and normal GH nadir that was seen in 13 patients. A pattern of high GH and normal IGF-1 was seen in 10 patients. There was a significant difference between the corrected IGF-1 values of the high IGF-1 group and those of active disease group (P=0.001). There was no significant difference in GHn between high GHn group and active disease group (P=0.8). Conclusion: There is a significant inconsistency between the results of IGF-1 and GHn in monitoring of acromegaly patients. Also, when GH-0 is<1 µg/L the use of GHn does not help and there is a need for more frequent monitoring for early diagnosis of the disease recurrence.